The chemical class known as PRAC1 Activators encompasses a diverse range of compounds that can activate PRAC1, a protein implicated in various cellular processes. These activators are identified based on their ability to influence cellular signaling pathways that are either directly or indirectly related to the function and regulation of PRAC1. The mechanisms through which these chemicals exert their effects vary widely, due to the different signaling pathways they modulate. The processes influenced by these chemicals include the upregulation of cyclic AMP (cAMP), modulation of protein kinase activity, alteration of intracellular calcium levels, and changes in chromatin structure and gene expression.
The activation of PRAC1 by these chemicals can occur through several distinct cellular events. For instance, some chemicals in this class can engage with adenylate cyclase, leading to an increased production of cAMP and subsequent activation of protein kinase A (PKA). PKA can then phosphorylate target proteins, which may include those that interact with or regulate PRAC1. Others can interact with protein kinase C (PKC), which is a pivotal player in signal transduction and can modulate other proteins that associate with PRAC1. Additionally, some activators can affect the levels of calcium ions within the cell, triggering calcium-dependent signaling mechanisms that can lead to the activation of PRAC1. Modifications in chromatin structure and gene expression patterns can also be a route through which these activators exert their influence, as they can alter the transcriptional landscape of the cell, potentially affecting PRAC1 expression. These chemical activators are thus integral to the fine-tuning of cellular signaling networks and can impact the functional state of PRAC1 within these complex biological systems.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels which can enhance PKA activity. PKA can phosphorylate various proteins, which could possibly activate PRAC1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A potent activator of protein kinase C (PKC); PKC is involved in signal transduction, which could possibly activate PRAC1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways, which could possibly activate PRAC1. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, causing DNA hypomethylation and gene expression changes, which could possibly activate PRAC1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, which could affect the MAPK signaling pathway and possibly activate PRAC1 through altered signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA, which could possibly activate PRAC1 through phosphorylation of related proteins. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
An inhibitor of protein phosphatases PP1 and PP2A, which could lead to increased phosphorylation of proteins, possibly activating PRAC1. | ||||||